Baramed Hyperbaric Chamber: Features, Specs and Buying Guide

The Baramed hyperbaric chamber line from Perry Baromedical is the gold standard for clinical monoplace HBOT in the United States. Perry Baromedical is ISO 13485:2016 certified, FDA-registered, and has been manufacturing chambers for hospitals globally for decades. This guide covers the Baramed specifications, the clinical use case, and when it makes sense vs alternatives.

The tissue oxygenation difference is significant: tissue O2 at 1.4 ATA measures approximately 161 mmHg vs 333 mmHg at 2.0 ATA in chronic wound patients — roughly half the oxygenation level.⁴ At 3.0 ATA with 100% O2, dissolved oxygen in plasma reaches levels 14x above the resting atmospheric baseline.

Perry Baromedical is the world leader in clinical hyperbaric systems, ISO 13485:2016 certified, with installations in hospitals globally. Their BARA-MED line saves approximately $8,000 per year in oxygen costs vs competitors — a meaningful operational advantage for high-volume clinical programs.¹

Key Technical Differentiators

Computerized Smooth Ride Pressure Control (Select/XD)

The BARA-MED Select and XD models use computerized pressure control to manage the rate of pressurization and depressurization. This reduces barotrauma risk and improves patient comfort during the session, particularly relevant for patients with active infections, recent surgeries, or Eustachian tube dysfunction.

Airbrake System (XD only)

The BARA-MED XD includes an airbrake system for controlled emergency decompression. In rare emergency situations (patient seizure, oxygen toxicity), controlled rapid decompression is possible without jarring pressure spikes. This is a safety feature relevant for clinical environments where compromised patients are treated.

Patient Communications

Full two-way communications with call button are standard on the XD model. Patients can signal distress, and clinical staff can monitor and respond without interrupting the session.

Monoplace vs Multiplace: The Clinical Choice

The BARA-MED monoplace treats one patient at a time in a 100% oxygen environment. The Perry Multiplace treats multiple patients simultaneously in a compressed air environment, with oxygen delivered via mask or hood.

The key clinical differences:

• ICU capability: Multiplace allows an inside attendant — critical for treating unstable patients with failing vital functions⁵
• Patient volume: Multiplace handles 2–20+ patients simultaneously, important for high-volume wound care programs
• Fire risk: Monoplace is filled with 100% O2 (higher fire risk); multiplace uses air (lower fire risk at the chamber level)
• Visual acuity changes: One study found 32% of monoplace patients reached 20/40 or worse vs 18% in multiplace settings⁶
• Cost: Monoplace $50,000–$150,000; Multiplace $500,000–$2,000,000+

Used and Refurbished Baramed Options

Perry Baromedical offers a used/refurbished program with OEM warranty on select units. For hospitals and clinics that want clinical-grade capability without new unit pricing, the refurbished market is meaningful. Sechrist Industries also offers a Certified Pre-Owned (CPO) program with a 90-day limited OEM warranty.

For organizations evaluating clinical chamber acquisition, comparing new Baramed units against refurbished Baramed or Sechrist CPO units is a standard evaluation step.

Baramed focuses on European manufacturing standards and ISO 13485:2016 quality management. For US clinical buyers, Perry Baromedical’s FDA-registered status and domestic manufacturing provide the strongest compliance and liability position available in clinical monoplace chambers.²

For home and wellness buyers, the Baramed line is not the right context. See our home chamber guide and our cost breakdown for consumer-appropriate options.

References

References

1. Perry Baromedical. BARA-MED product specifications and oxygen cost savings data. perrybaromedical.com. Accessed May 2026.
2. ISO 13485:2016 Medical devices quality management systems. iso.org. Accessed May 2026.
3. UHMS. Hyperbaric Oxygen Therapy Indications, 14th ed. uhms.org. Accessed May 2026.
4. Sack RA et al. Transcutaneous oximetry values in chronic ulcer patients at 1.4 ATA vs 2 ATA. Undersea & Hyperbaric Medicine. 2023. PMID: 38615347
5. Lind F. A pro/con review comparing mono- and multiplace hyperbaric chambers for critical care. Diving and Hyperbaric Medicine. 2015. PMID: 25964041
6. Churchill S et al. Rates of visual acuity change in patients receiving HBO2 in monoplace and multiplace chambers. Undersea & Hyperbaric Medicine. 2016. PMID: 27416689

Related Guides

• Best Hyperbaric Chambers – Full market rankings including clinical options
• Zeugma Clinical Chambers – International clinical alternative
• Eclipse Elite – US-made 1.5 ATA option for wellness/clinic
• HBOT Therapy Guide – How to find clinical HBOT near you
• Cost Guide – Clinical vs home chamber pricing

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website